Side-by-side matrix of up to 4 real CDMO records — the six deterministic scoring engines, capacity & quality metrics and capability matrices, with the best value in each numeric row highlighted.
Scores deterministic, rules-based — not AI. Illustrative data. Organization names are real CDMOs / contract manufacturers; all capabilities, capacity, equipment, GMP certifications, inspection history, quality metrics and performance figures are synthetic demonstration data — verify directly and via vendor qualification before any manufacturing-sourcing decision.
CDMO scorecard · deterministic 0–100 iCapability scores are a directional starting point, not a verdict. A lower score does not disqualify a company or consultant, and no decision should rest on the score alone — always contact the company directly to confirm the specifics for your project.
Manufacturing breadth iHow wide the CDMO's modality coverage is across drug-substance, drug-product, advanced-therapy and specialized capabilities plus therapeutic areas — broader coverage scores higher.
79
61
48
59
Advanced-therapy strength iDepth in cell, gene, viral-vector, CAR-T and exosome therapies, plus biologics drug substance, mRNA and plasmid-DNA capability.
69
58
94
26
Fill-finish capacity iSterile fill-finish reach across vial, syringe, cartridge, blow-fill-seal and isolator/RABS filling, weighted by the number of filling suites.
76
68
52
76
Quality & compliance iGMP certification, Annex 1 and data-integrity programs combined with inspection-pass rate, quality score and few open CAPAs or audit findings.
0
0
0
0
Regulatory reach iBreadth of regulatory filing history, inspecting-authority coverage and the number of geographies the CDMO can supply.
6
24
12
24
Capacity scale iOverall manufacturing scale from facility count, filling-suite count, annual production capacity and global headcount.